Sanity Group GmbH

About Sanity Group GmbH

Sanity Group is dedicated to unlocking the health benefits of cannabinoids, aiming to improve well-being through medical expertise and strategic guidance from advisory boards.

Products & Services

vaay:A brand under Sanity Group, likely focused on cannabinoid-related products.

Endosane Pharmaceuticals:A pharmaceutical brand under Sanity Group, focused on cannabinoid-based treatments.

Specialties

Cannabinoid health benefits Medical cannabis research Recreational cannabis pilot projects Harm reduction through legal cannabis distribution

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Unsecured Convertible Note and Equity Investment T: - FT: Unsecured Convertible Note and Equity Investment	A: 14980000 MR: - FA: €14 million FAN: 14980000	D: 2024-06-25 FD: 2024-06-25	1 investors

Unsecured Convertible Note and Equity Investment Latest

2024-06-25

$15.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

F

Finn Hänsel

MANAGING DIRECTOR & FOUNDER

F

Fabian Friede

ADVISOR & FOUNDER

K

Kirsten Müller-Vahl

Professor of Psychiatry

T

Thomas Herdegen

Professor

J

Joachim Nadstawek

Specialist in Anesthesia

D

Dennis Stracke

Pharmacist and Head of Neurology Department

View 16 more team members with Pro

Unlock Full Team Directory

Recent News